Bio

Nader joined Frazier Healthcare Partners in 1991 and has served on the firm’s management committee and led its Growth Buyout strategy since 1995. Under his leadership, the team has scaled from an initial group of four to over sixty dedicated professionals and raised over $5 billion from Limited Partners globally for 10 investment vehicles that have generated over $4 billion in realizations to date. During his more than three-decade tenure with the firm, he has been responsible for and served on the boards of successful investments in Aspen Education Group (served as Chairman and acquired by Bain Capital), CHG Healthcare (acquired by J.W. Childs Associates), Priority Solutions International (acquired by Thermo Fisher NASDAQ: TMO), Bravo Health (acquired by HealthSpring which was subsequently acquired by Cigna NYSE: CI), Laboratory Supply Company (acquired by McKesson NYSE: MCK), Pentec Health (Acquired by NEP), Solis Mammography (acquired by Madison Dearborn), DSI Renal (merged with U.S. Renal Care and ultimately acquired by Bain Capital) and Northfield Medical (acquired by Agiliti, Inc.). He currently serves on the Boards of United Digestive, Alteon Health, Elevate Patient Financial Solutions (previously MedData), and Accuity Delivery Systems. Prior to joining Frazier, he was an Associate at Goldman Sachs in New York. Mr. Naini received his MBA from the Leonard N. Stern School of Business at New York University and a BA in Molecular Biology from the University of Pennsylvania.